Bioequivalence study of a medicinal product is a type of clinical trials conducted to determine the rate of absorption and excretion of the pharmaceutical substance and the quantity of the pharmaceutical substance reaching the systemic blood flow, the results of which trial allow drawing an inference of bioequivalence of a certain dosage form and dosage rate of a generic medicinal product to the originator medicinal product

Source: Russian Federation Law №61-FZ March 24, 2010 "On Circulation of Medicines"